Gene-edited chickens to combat bird flu: Saviour or liability?
By Claire Robinson,
GMWatch
| 10. 19. 2023
Chicken farm by "L214 - éthique et animaux"
from Wiki Commons, licensed under CC by 3.0.
Scientists at the University of Edinburgh’s Roslin Institute — the animal research centre where Dolly the sheep was created — have used CRISPR gene editing to develop chickens that resist infection by bird flu, a disease that has decimated some wild bird populations and commercial poultry flocks across the world. But there are serious risks and limitations in the research, which were even indicated by the scientists involved but were largely ignored or downplayed by mainstream media outlets.
A press statement by the Roslin called the gene-edited chickens a “significant step in bird flu fight” and said, “Alterations to key gene associated with infection offer partial protection and suggest [a] path to flu-resistant poultry”. The findings are published in Nature Communications.
The Roslin reported that the scientists used gene-editing techniques to identify and change parts of chicken DNA that could limit the spread of avian flu in the birds. The bird flu virus needs a protein present in chicken cells, ANP32A, to...
Related Articles
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...